Providing class leading solutions and high quality cGMP bio-manufacturing services to advance the Regenerative Medicine, Cell Therapy & ART/IVF markets.
Grateful to @Phacilitate for spotlighting @casebioscience at Advanced Therapies Week 2026, with Kevin Flynn.
Beyond Viability: Designing Cryopreservation Systems for Cell Therapy https://t.co/KXEDgOfopL via @YouTube
CaseBioscience® is advancing next-gen biopreservation for cell therapy! See CaseCryo® CTG DMSO & CaseStor® HSS, launching at ATW 2026. Full details in our latest press release. https://t.co/b4XHNn5M40
CaseBioscience is thrilled to announce our debut as an exhibitor at the @ASRM_org Annual Meeting in Denver, Colorado, from October 20-24, 2024! 🎉 Come find us at Booth 143!
#ASRM#ART#IVF
We are proud to sponsor & exhibit at the @BioProcessIntl conference for cell therapy manufacturing & commercialization in Boston , Sept 23-26. Come visit booth 1615 to discuss our innovate CaseCryo DMSO & Non-DMSO solutions. #BPI2024#celltherapy#cryopreservation
What an incredible start to #Phacilitate Advanced Therapies Week! It’s been such an opportunity, introducing CaseBioscience and our cGMP #cryopreservation media solutions to the community while building new partnerships and relationships in cell therapy. #ATW24#cgt#celltherapy
We're exhibiting at @Phacilitate Advanced Therapies Week in Miami on January 2024. We look forward to seeing you all there. #advancedtherapies#biotech https://t.co/AjywS5rxBI
We're exhibiting at @Phacilitate Advanced Therapies Week in Miami on January 2024. We look forward to seeing you all there. #advancedtherapies#biotech https://t.co/AjywS5rxBI
Visit us at @PlanerLtd booth for #SLTB2023 in Vigo, Spain. Our CSO Dr. Kevin Flynn will be presenting on our innovative non-dmso cryopreservation solutions for #celltherapy applications.
#casebioscience
CaseBioscience is currently hiring for multiple open positions across our organization. Please visit the Job openings page of https://t.co/Mki8QHNhL0 or apply directly via email at [email protected] https://t.co/wbmAHTEyZQ